Skip to content
A Green Sign – Lifestyle
Author:
CRISPR Therapeutics AG
CRISPR Therapeutics to Present Clinical Data from Zugo-cel in Large B-Cell Lymphoma at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition
November 4, 2026
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results
November 2, 2026
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer
November 2, 2026
CRISPR Therapeutics Announces Chief Financial Officer Transition
October 19, 2026
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026
October 8, 2026
CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026
October 2, 2026
CRISPR Therapeutics to Present at Morgan Stanley Global Healthcare Conference
September 8, 2026
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
August 3, 2026
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
May 28, 2026